Pecorari Isabella L, Mahali Lakshmi Priyanka, Funari Abigail, Fecher Roger, Suda Nisha, Agarwal Vijay
Department of Neurological Surgery, Albert Einstein College of Medicine, Bronx, New York, United States.
Department of Neurological Surgery, Montefiore Medical Center, Bronx, New York, United States.
J Neurol Surg Rep. 2022 May 27;83(2):e33-e38. doi: 10.1055/s-0042-1749389. eCollection 2022 Apr.
Clinically silent double pituitary adenomas consisting of corticotroph and somatotroph cells are an exceedingly rare clinical finding. In this report, we present the case of a 28-year-old man with a 1-year history of recurrent headaches. Imaging revealed a 2.1 (anterior-posterior) × 2.2 (transverse) × 1.3 (craniocaudal) cm pituitary adenoma invading into the left cavernous sinus and encasing the left internal carotid artery. Endoscopic transnasal resection was performed without complications. Immunohistochemical staining revealed a double adenoma consisting of distinct sparsely granulated somatotroph and densely granulated corticotroph cells that were positive for growth hormone and adrenocorticotropic hormone, respectively. K -67 index labeling revealed a level of 6% within the corticotroph adenoma. No increase in serum growth hormone or adrenocorticotropic hormone was found, indicating a clinically silent double adenoma. While transsphenoidal surgery remains a first-line approach for silent adenomas presenting with mass effects, increased rates of proliferative markers, such as the K -67 index, provide useful insight into the clinical course of such tumors. Determining the K -67 index of silent pituitary adenomas could be valuable in predicting recurrence after initial surgical resection and identifying tumors that are at an increased risk of needing additional therapeutic interventions or more frequent surveillance imaging.
由促肾上腺皮质激素细胞和生长激素细胞组成的临床无症状性双垂体腺瘤是一种极为罕见的临床发现。在本报告中,我们介绍了一名28岁男性患者,有1年复发性头痛病史。影像学检查发现一个大小为2.1(前后径)×2.2(横径)×1.3(颅尾径)cm的垂体腺瘤,侵犯左侧海绵窦并包绕左侧颈内动脉。行鼻内镜经鼻切除术,无并发症发生。免疫组化染色显示为双腺瘤,由分别对生长激素和促肾上腺皮质激素呈阳性的不同的稀疏颗粒状生长激素细胞和密集颗粒状促肾上腺皮质激素细胞组成。K -67指数标记显示促肾上腺皮质激素腺瘤内的水平为6%。未发现血清生长激素或促肾上腺皮质激素升高,表明为临床无症状性双腺瘤。虽然经蝶窦手术仍然是有占位效应的无症状腺瘤的一线治疗方法,但增殖标志物(如K -67指数)的升高率为了解此类肿瘤的临床病程提供了有用的见解。确定无症状垂体腺瘤的K -67指数对于预测初次手术切除后的复发以及识别有增加额外治疗干预或更频繁监测成像风险的肿瘤可能具有重要价值。